Provided by Tiger Trade Technology Pte. Ltd.

Perspective Therapeutics

3.10
0.0000
Post-market: 3.150.0500+1.61%17:06 EDT
Volume:864.62K
Turnover:2.68M
Market Cap:353.40M
PE:-2.33
High:3.24
Open:3.10
Low:3.03
Close:3.10
52wk High:6.16
52wk Low:1.96
Shares:114.00M
Float Shares:67.88M
Volume Ratio:1.05
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3300
EPS(LYR):-1.3971
ROE:-39.57%
ROA:-22.28%
PB:1.09
PE(LYR):-2.22

Loading ...

Perspective Therapeutics Highlights Encouraging Interim Neuroendocrine Tumor Data

TIPRANKS
·
Apr 20

BUZZ-Perspective Therapeutics rises as experimental cancer drug shows promise

Reuters
·
Apr 20

Perspective reports results from Phase 1/2a clinical trial of (212Pb)VMT-alpha-NET

TIPRANKS
·
Apr 20

Perspective Therapeutics reports 43% response rate in [212Pb]VMT-α-NET Phase 1/2a trial

Reuters
·
Apr 20

Perspective Therapeutics Presents Updated Interim Data of [212PB]Vmt-Α-Net in Its Ongoing Phase 1/2a Clinical Trial at the 2026 Aacr Annual Meeting

THOMSON REUTERS
·
Apr 20

Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting

GlobeNewswire
·
Apr 20

Perspective Therapeutics announces annual shareholder meeting

Reuters
·
Apr 17

Perspective Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Apr 02

Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline

TIPRANKS
·
Apr 02

Perspective Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 23

Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright

TIPRANKS
·
Mar 23

Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Gain Therapeutics (GANX)

TIPRANKS
·
Mar 21

Perspective Therapeutics price target raised to $8 from $7 at UBS

TIPRANKS
·
Mar 19

Perspective Therapeutics Price Target Maintained With a $11.00/Share by Wedbush

Dow Jones
·
Mar 18

B. Riley Raises Price Target on Perspective Therapeutics to $13 From $11, Keeps Buy Rating

MT Newswires Live
·
Mar 18

Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX)

TIPRANKS
·
Mar 18

Perspective Therapeutics to present [212Pb]VMT-α-NET data at AACR Annual Meeting 2026

Reuters
·
Mar 18

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), DocGo (DCGO) and Editas Medicine (EDIT)

TIPRANKS
·
Mar 17

BTIG Reaffirms Their Buy Rating on Perspective Therapeutics (CATX)

TIPRANKS
·
Mar 17

Perspective Therapeutics Price Target Maintained With a $14.00/Share by BTIG

Dow Jones
·
Mar 17